US drug giant Pfizer beats GSK to UK government contract for 4.9m vaccine shots Healthcare Pfizer has beaten GSK to win a contract to supply millions of doses of a new respiratory vaccine in the UK after the government snubbed the local drugmaker.
GSK shares drag the FTSE 100 as company faces muli-billion pound bill after Zantac trial ruling pharma GSK has hit back against a US ruling that found it could be sued over the potential cancer-causing properties of its heartburn drug Zantac.
GSK: How much could the Zantac lawsuits cost? Pharma Last month, Shore Capital analysts estimated that up to $30bn (£24bn) for litigation was already priced into GSK’s shares.
Polar Capital Healthcare trust rockets to success thanks to strong stock selection May 16, 2024 The trust performed much better than the previous year, where it grew only 4.2 per cent, thanks to strong stock selection and managing to outperform an already booming healthcare market.